MYD88 and metabolic disease: T cell-specific knockout of myeloid differentiation primary response 88 (MyD88) results in abnormal IgA antibody responses and an altered microbial gut community, leading to more severe inflammatory diseases, age-associated obesity, and metabolic disorders (16, 53).